Has the SPRINT trial introduced a new blood-pressure goal in hypertension?
- Ruiz Hurtado, Gema
- Banegas, José R.
- Sarafidis, Pantelis A.
- Volpe, Massimo
- Williams, Bryan
- Ruilope Urioste, Luis Miguel
DOIAbstract
SPRINT is the first randomized, controlled trial showing that a systolic blood-pressure goal of <120 mmHg can be attained with cardiovascular benefits in a select group of patients with hypertension and an elevated cardiovascular risk with different origins. Although the patient population with characteristics like those in SPRINT makes up only 20–30% of the total hypertensive population, SPRINT is a landmark study that highlights the need to consider lower blood- pressure goals in the treatment of hypertension. Extending this study to include other patient populations and geographical areas is the next step for evaluating the benefits of strict blood-pressure targets and the generalizability of the SPRINT results. Importantly, the blood-pr...
Add to ORKG